To test whether syndecan-4 binding to MLP was affected by any of the HCM- or DCM-associated mutations, we used an ELISA-based assay, where wells were coated with WT or mutated MLP peptide sequences. This evidence concerns the gene CSRP3 and familial dilated cardiomyopathy.